ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,949Medicare Part D Prescriptions Filled, Including Refills

Rank: 112 out of 663

$393K Total Retail Price of All Prescriptions

Rank: 140 out of 663

432 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 432 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

15% of this provider’s 432 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 7,601 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LEVOTHYROXINE SODIUM 581 572 1 3
SIMVASTATIN 385 366 2 1
AMLODIPINE BESYLATE 311 307 3 5
LISINOPRIL 279 257 4 2
HYDROCODONE-ACETAMINOPHEN 266 266 S3 5 6
CITALOPRAM HBR 228 218 6 18
LOSARTAN POTASSIUM 224 224 7 14
ZOLPIDEM TARTRATE 218 211 8 16
OMEPRAZOLE 212 205 9 4
FUROSEMIDE 176 161 10 7
ATORVASTATIN CALCIUM 164 163 11 13
WARFARIN SODIUM 154 146 12 8
TRAMADOL HCL 144 141 13 17
GLIPIZIDE 138 138 14 29
HYDROCHLOROTHIAZIDE 133 133 15 12
GABAPENTIN 131 127 16 20
ATENOLOL 130 127 17 10
METOPROLOL TARTRATE 129 115 18 11
TRAZODONE HCL 122 122 19 34
VENLAFAXINE HCL ER 112 100 20 86
DONEPEZIL HCL 112 112 20 40
POTASSIUM CHLORIDE 109 104 22 23
METOPROLOL SUCCINATE 104 104 23 25
ALENDRONATE SODIUM 100 97 24 15
PRAVASTATIN SODIUM 86 74 25 21
CIPROFLOXACIN HCL 84 80 26 74
MIRTAZAPINE 75 75 27 52
PANTOPRAZOLE SODIUM 66 66 28 45
TAMSULOSIN HCL 62 62 29 24
METFORMIN HCL 62 61 29 9
LOVASTATIN 60 57 31 30
TRIAMTERENE-HCTZ 58 58 32 42
FLUTICASONE PROPIONATE 57 55 33 27
FAMOTIDINE 57 53 33 76
CARVEDILOL 51 51 35 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 19, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.